This observation is reminiscent of the mechanism observed in lipoma, where truncation of another oncogene, HMGA2, and its fusion with NFIB results in loss of miRNA target sites, which consequently leads to deregulated HMGA2 expression [51]. The gene discussed is NFIB; the disease is lipoma.